PT  - JOURNAL ARTICLE
AU  - Zuck, Meghan
AU  - Green, Kevin
AU  - Pisarenko, Tatyana
AU  - Dinh, Huyen
AU  - Bouchlaka, Myriam
AU  - Zapata, Francisco
AU  - Hay, Elsa L
AU  - Naika, Gajendra
AU  - Heit, Jacob
AU  - Fox, Ray
AU  - Whitman, Darbie
AU  - Graddis, Tom
AU  - Puri, Kamal D
AU  - Probst, Peter
TI  - 519 OR641 is a novel dual antagonist antibody that targets LILRB1 and LILRB2 inhibitory receptors and promotes a Th1-like immune response
AID  - 10.1136/jitc-2023-SITC2023.0519
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A585--A585
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A585.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A585.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.